Bellemin Jean-Marc — SEC Form 4 filings

SEC reporting owner CIK 1754253. 5 Form 4 filings on record with FilingPulse; latest filed 2025-06-04.

Transaction summary — filings shown

Covers all 5 filings on record, filed 2024-03-05 to 2025-06-04. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
IOVANCE BIOTHERAPEUTICS, INC. (IOVA)Chief Financial Officer512

Form 4 filings — Bellemin Jean-Marc

FiledFormIssuerReported transactionsSource
2025-06-044IOVANCE BIOTHERAPEUTICS, INC. (IOVA)Option exercise (M): 8,789 @ $0 · Tax withholding (F): 4,464 @ $1.76 · Option exercise (M): 8,789 (derivative) @ $0EDGAR
2025-03-074IOVANCE BIOTHERAPEUTICS, INC. (IOVA)Grant/award (A): 93,750 (derivative) @ $0EDGAR
2025-03-054IOVANCE BIOTHERAPEUTICS, INC. (IOVA)Option exercise (M): 58,590 @ $0 · Tax withholding (F): 31,734 @ $4.04 · Option exercise (M): 58,590 (derivative) @ $0EDGAR
2024-09-054IOVANCE BIOTHERAPEUTICS, INC. (IOVA)Option exercise (M): 23,438 @ $0 · Tax withholding (F): 11,891 @ $10.85 · Option exercise (M): 23,438 (derivative) @ $0EDGAR
2024-03-054IOVANCE BIOTHERAPEUTICS, INC. (IOVA)Grant/award (A): 105,470 (derivative) @ $0 · Grant/award (A): 46,875 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1754253 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →